Previous 10 | Next 10 |
2023-08-30 04:41:17 ET More on Inotiv Inotiv a new overweight at Wells Fargo on earnings growth, valuation Inotiv downgraded to hold at Jefferies on non-human primate supply issues Seeking Alpha’s Quant Rating on Inotiv For further details see: Ino...
WEST LAFAYETTE, Ind., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and developm...
WEST LAFAYETTE, Ind., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and developm...
2023-08-11 12:55:32 ET Gainers: Amyris ( AMRS ) +135% . Rigetti Computing ( RGTI ) +45% . Bitdeer Technologies Group ( BTDR ) +43% . Telesat Corporation ( TSAT ) +40% . MicroCloud Hologram ( HOLO ) +29% . Evolv Technologies H...
2023-08-11 10:14:56 ET Gainers: Eton Pharmaceuticals ( ETON ) +23% . Semler Scientific ( SMLR ) +20% . ModivCare ( MODV ) +15% . Erasca ( ERAS ) +9% . Relmada Therapeutics ( RLMD ) +8% . Losers: Cano Health ( CANO ) -...
2023-08-10 22:31:04 ET Inotiv, Inc. (NOTV) Q3 2023 Earnings Conference Call Aug 10, 2023 4:30 PM ET Company Participants Bob Yedid - LifeSci Advisors, Investor Relations Bob Leasure - Chief Executive Officer, President, and Director Beth Taylor - Senior Vice Pres...
2023-08-10 16:29:28 ET Inotiv press release ( NASDAQ: NOTV ): Q3 GAAP EPS of $0.07 beats by $0.17 . Revenue of $157.5M (-8.8% Y/Y) beats by $6.42M . Recasting full year revenue guidance to at least $570 million in revenue, which is down from $580 million in pre...
WEST LAFAYETTE, Ind., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and developm...
WEST LAFAYETTE, Ind., July 24, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and developm...
2023-07-20 10:23:14 ET Gainers: PainReform ( PRFX ) +55% . T2 Biosystems ( TTOO ) +19% . Inotiv ( NOTV ) +15% . Tarsus Pharmaceuticals ( TARS ) +14% . Nanobiotix ( NBTX ) +11% . Losers: Vir Biotechnology ( VIR ) ...
News, Short Squeeze, Breakout and More Instantly...
WEST LAFAYETTE, Ind., June 10, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and rela...